Proscia raises $9 million in an extension of its Series C funding round, bringing the total round to $46 million. The funding will be used to accelerate Proscia’s commercial growth and further develop its AI-powered applications for life sciences and diagnostic laboratories. With FDA clearance, Proscia can now bring its digital pathology solutions to diagnostic labs.
- #ai#data-science#business#nlp#automation#big-data#healthcare#conversational-ai#data-management#predictive-analytics#data-labelling
Table of contents
Unlocking the power of digital pathology and AILeading the digital pathology transformation70 Impressions